ROYAL BANK OF CANADA - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 100 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$63,000
+250.0%
5,618
+246.4%
0.00%
Q2 2017$18,000
+12.5%
1,622
+1.4%
0.00%
Q1 2017$16,000
-61.0%
1,600
-58.2%
0.00%
Q4 2016$41,000
+156.2%
3,832
+136.1%
0.00%
Q3 2016$16,000
-27.3%
1,623
-4.5%
0.00%
Q2 2016$22,000
-8.3%
1,700
-22.7%
0.00%
Q1 2016$24,000
-91.9%
2,200
-93.2%
0.00%
Q4 2015$297,000
+1385.0%
32,285
+981.9%
0.00%
Q3 2015$20,000
-95.9%
2,984
-94.0%
0.00%
Q2 2015$487,000
+14.1%
49,679
+3.2%
0.00%
Q1 2015$427,000
+2568.8%
48,147
+2574.8%
0.00%
Q4 2014$16,000
+14.3%
1,800
-10.0%
0.00%
Q3 2014$14,000
-22.2%
2,000
-42.9%
0.00%
Q2 2014$18,000
+63.6%
3,500
+40.0%
0.00%
Q1 2014$11,000
+120.0%
2,500
+150.0%
0.00%
Q4 2013$5,000
-95.2%
1,000
-95.2%
0.00%
Q3 2013$105,000
+1650.0%
20,688
+1508.7%
0.00%
Q2 2013$6,0001,2860.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,663,281$16,300,0009.19%
Nantahala Capital Management 1,891,328$18,535,0002.06%
Nine Chapters Capital Management LLC 40,700$399,0000.54%
MENTA CAPITAL LLC 396,336$3,884,0000.38%
Sapphire Star Partners LP 30,439$298,0000.34%
TFS CAPITAL LLC 95,432$935,0000.30%
Ativo Capital Management LLC 123,428$1,210,0000.30%
GLG Partners LP 363,188$3,559,0000.17%
GSA CAPITAL PARTNERS LLP 240,013$2,352,0000.13%
Bowling Portfolio Management LLC 68,473$671,0000.11%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders